Holen Sie sich die Stockscreener-App
81.38
0.90%
0.71
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$80.67
Offen:
$80.73
24-Stunden-Volumen:
3.94M
Relative Volume:
0.52
Marktkapitalisierung:
$103.18B
Einnahmen:
$386.46B
Nettoeinkommen (Verlust:
$4.49B
KGV:
22.71
EPS:
3.5841
Netto-Cashflow:
$4.78B
1W Leistung:
+6.07%
1M Leistung:
+10.78%
6M Leistung:
+18.75%
1J Leistung:
+25.19%
1-Tages-Spanne:
$80.63
$81.91
1-Wochen-Bereich:
$77.37
$81.93
52-Wochen-Spanne:
$43.56
$81.93
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
81.35 | 101.03B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
UNH
Unitedhealth Group Inc
|
354.94 | 325.98B | 422.82B | 22.09B | 25.27B | 23.09 |
|
ELV
Elevance Health Inc
|
347.81 | 78.92B | 189.25B | 5.35B | 5.34B | 23.49 |
|
CI
Cigna Group
|
290.13 | 80.65B | 261.22B | 5.40B | 3.94B | 18.31 |
|
HUM
Humana Inc
|
266.50 | 31.46B | 123.11B | 1.58B | 2.44B | 13.03 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS takes over Rite Aid assets in bankruptcy deal - Yahoo
CVS polishes off deal to buy former Rite Aid stores, prescription files - Hartford Courant
Shoppers trust pharmacists and want one-on-one care: report - Supermarket News
CVS finalises purchase of Rite Aid stores and assets - Yahoo Finance
CVS is closing hundreds of stores nationwide: Here’s where - AOL.com
The Pharmacy Stock That's Cheaper Than It Should Be - AOL.com
CVS Health Corporation (CVS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
CVS completes acquisition of 63 Rite Aid stores, 626 prescription files - Investing.com
CVS Acquires Rite Aid Assets to Expand Nationwide Presence - GuruFocus
CVS Health price target raised to $89 from $82 at Morgan Stanley - Yahoo Finance
63 former Rite Aid & Bartell stores: CVS completes acquisition, now serving more than 9 million former patients - Stock Titan
CVS Health EVP Capozzi buys shares worth $4588 By Investing.com - Investing.com South Africa
Ambulatory Infusion Center Market Growth Driven by Rising - openPR.com
CVS Health EVP Capozzi buys shares worth $4588 - Investing.com
How to build a custom watchlist for CVS Health CorporationJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
CVS Health (CVS) Sees Analyst Raise Price Target to $89 | CVS St - GuruFocus
Goldman Sachs Initiates Coverage on CVS Health with a Buy Rating | CVS Stock News - GuruFocus
Jim Cramer Admits He Was Wrong About CVS Health’s (CVS) Aetna - Yahoo Finance
77% of adults trust pharmacists — CVS Health 2025 Rx Report: 80% prefer in-person care; tech aids teams - Stock Titan
CVS Health Corporation $CVS Shares Sold by Community Bank N.A. - MarketBeat
Why CVS Health Corporation is moving todayMarket Trend Report & Verified Stock Trade Ideas - newser.com
CVS Health (NYSE:CVS) Hits New 52-Week HighShould You Buy? - MarketBeat
Recent Cases Spotlight Retention Lessons for AI Content from Video Recordings - JD Supra
Cvs Health Corp stock hits 52-week high at 79.21 USD - Investing.com Canada
Is now a turning point for CVS Health CorporationCEO Change & Short-Term High Return Ideas - newser.com
CVS Launches Workforce Innovation and Talent Center and Community Resource Center in Fort Worth - Yahoo Finance
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock? - Yahoo Finance
Concord Asset Management LLC VA Buys Shares of 34,078 CVS Health Corporation $CVS - MarketBeat
Yousif Capital Management LLC Has $15.60 Million Stake in CVS Health Corporation $CVS - MarketBeat
Pzena Investment Management LLC Sells 935,521 Shares of CVS Health Corporation $CVS - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 21,544 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Tops US Medicare Quality Ratings For 2026 - Finimize
Is CVS Health Corporation stock in correction or buying zoneJuly 2025 Spike Watch & Accurate Buy Signal Alerts - newser.com
Using Bollinger Bands to evaluate CVS Health Corporation2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Rep. Val T. Hoyle Sells CVS Health Corporation (NYSE:CVS) Shares - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Means Investment CO. Inc. - MarketBeat
GFS Advisors LLC Has $248,000 Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Aberdeen Group plc - MarketBeat
US Bancorp DE Lowers Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Thompson Investment Management Inc. - MarketBeat
Mengis Capital Management Inc. Decreases Position in CVS Health Corporation $CVS - MarketBeat
Commerzbank Aktiengesellschaft FI Purchases 10,795 Shares of CVS Health Corporation $CVS - MarketBeat
Coerente Capital Management Reduces Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Venturi Wealth Management LLC Takes $259,000 Position in CVS Health Corporation $CVS - MarketBeat
Belpointe Asset Management LLC Trims Stake in CVS Health Corporation $CVS - MarketBeat
3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026 - The Motley Fool
How Recent Developments Are Rewriting the Story for CVS Health - Yahoo Finance
CVS Health (CVS) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Why CVS Health Corporation (CVS) stock appeals to dividend investorsWeekly Volume Report & Daily Price Action Insights - newser.com
CVS Health (NYSE:CVS) Given New $88.00 Price Target at Mizuho - MarketBeat
CVS Health Leads In Top-Rated Medicare Plans, Edging Out Rivals - Finimize
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
1.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):